Tremblay, Douglas
Mayo Clinic
a Icahn School of Medicine at Mount Sinai , Tisch Cancer Institute , New York , NY , USA.
Citations 1
Phase II trial of Lestaurtinib, a JAK2 inhibitor, in patients with myelofibrosis
Mascarenhas, John , Baer, Maria R. , Tremblay, Douglas , Price, Leah , Sandy, Lonette, Weinberg, Rona Singer , Pahl, Heike L. , Silverman, Lewis R. , Dueck, Amylou C. , Tremblay, Douglas , Dueck, A. C. , Mascarenhas, John , Price, Leah , Kessler, Craig M. , Hexner, Elizabeth O. , Goldberg, Judith D. , Kosiorek, Heidi , Hoffman, Ronald , Tremblay, Douglas
Leukemia & Lymphoma | January 23, 2019 | Volume: 60 | Issue: 5 | Pages: 1343-1345
